← Back to Clinical Trials
Recruiting NCT03735992
Mind-body Medicine for Patients With Malignant Hematological Diseases
Trial Parameters
Condition Hematologic Neoplasms
Sponsor Universität Duisburg-Essen
Study Type INTERVENTIONAL
Phase N/A
Enrollment 94
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2017-09-06
Completion 2025-12-31
Interventions
Mind-body medicine group program
Brief Summary
This randomized controlled trial aims to investigate the effectiveness of a mind-body group program as a supprtivemanagement strategy for fatigue in patients with malignant hematological diseases.
Eligibility Criteria
Inclusion Criteria: * Patients with malignant hematological diseases in complete remission after primary chemotherapy and/or radiation * Physical and mental ability to attent 8 of 11 group units Exclusion Criteria: * Chemotherapy, radiation, or rehabilitation programm during the study period * Pregnancy * Participation in other studies with behavioral interventions during the study period